

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of action potential (GO:0045760) | 5.59910269 |
| 2 | tachykinin receptor signaling pathway (GO:0007217) | 5.23417708 |
| 3 | somite rostral/caudal axis specification (GO:0032525) | 4.81991292 |
| 4 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.56397166 |
| 5 | neural tube formation (GO:0001841) | 4.48955856 |
| 6 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.45670910 |
| 7 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.45670910 |
| 8 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.45670910 |
| 9 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.40744960 |
| 10 | regulation of action potential (GO:0098900) | 4.38258192 |
| 11 | behavioral response to ethanol (GO:0048149) | 4.35309437 |
| 12 | cell wall macromolecule catabolic process (GO:0016998) | 4.26306425 |
| 13 | regulation of establishment of cell polarity (GO:2000114) | 4.16041478 |
| 14 | acrosome assembly (GO:0001675) | 4.05752724 |
| 15 | retinal ganglion cell axon guidance (GO:0031290) | 3.96386296 |
| 16 | heparin biosynthetic process (GO:0030210) | 3.83822230 |
| 17 | heparin metabolic process (GO:0030202) | 3.83822230 |
| 18 | regulation of glucocorticoid secretion (GO:2000849) | 3.83522585 |
| 19 | platelet dense granule organization (GO:0060155) | 3.78770957 |
| 20 | * detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.76569471 |
| 21 | positive regulation of developmental pigmentation (GO:0048087) | 3.73533249 |
| 22 | proline transport (GO:0015824) | 3.73509686 |
| 23 | negative regulation of multicellular organism growth (GO:0040015) | 3.69185352 |
| 24 | interkinetic nuclear migration (GO:0022027) | 3.67892871 |
| 25 | protein localization to cilium (GO:0061512) | 3.67683530 |
| 26 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.66805657 |
| 27 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.59237714 |
| 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.58200814 |
| 29 | regulation of pigment cell differentiation (GO:0050932) | 3.55410958 |
| 30 | sex differentiation (GO:0007548) | 3.45298181 |
| 31 | cell wall macromolecule metabolic process (GO:0044036) | 3.42773010 |
| 32 | microtubule anchoring (GO:0034453) | 3.42616636 |
| 33 | left/right axis specification (GO:0070986) | 3.39438084 |
| 34 | * detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.37394058 |
| 35 | nuclear pore complex assembly (GO:0051292) | 3.36604860 |
| 36 | regulation of telomere maintenance (GO:0032204) | 3.33803396 |
| 37 | positive regulation of protein deacetylation (GO:0090312) | 3.32983565 |
| 38 | regulation of feeding behavior (GO:0060259) | 3.29129862 |
| 39 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.28938884 |
| 40 | regulation of memory T cell differentiation (GO:0043380) | 3.24172610 |
| 41 | synapsis (GO:0007129) | 3.16176426 |
| 42 | negative regulation of heart rate (GO:0010459) | 3.14659776 |
| 43 | stress granule assembly (GO:0034063) | 3.09589399 |
| 44 | DNA ligation (GO:0006266) | 3.07702902 |
| 45 | establishment of protein localization to Golgi (GO:0072600) | 3.07031949 |
| 46 | neuronal action potential propagation (GO:0019227) | 3.06815499 |
| 47 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 3.06578176 |
| 48 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.03224721 |
| 49 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.98749177 |
| 50 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.97726639 |
| 51 | behavioral response to nicotine (GO:0035095) | 2.94261330 |
| 52 | synaptic transmission, cholinergic (GO:0007271) | 2.92134888 |
| 53 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.91756537 |
| 54 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.91442627 |
| 55 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.90967373 |
| 56 | regulation of protein deacetylation (GO:0090311) | 2.89359927 |
| 57 | nuclear pore organization (GO:0006999) | 2.88659729 |
| 58 | central nervous system neuron axonogenesis (GO:0021955) | 2.87158293 |
| 59 | intraciliary transport (GO:0042073) | 2.85394807 |
| 60 | prenylation (GO:0097354) | 2.82164267 |
| 61 | protein prenylation (GO:0018342) | 2.82164267 |
| 62 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.81510273 |
| 63 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.81510273 |
| 64 | microtubule nucleation (GO:0007020) | 2.81327814 |
| 65 | pore complex assembly (GO:0046931) | 2.80519265 |
| 66 | RNA destabilization (GO:0050779) | 2.75992571 |
| 67 | ADP metabolic process (GO:0046031) | 2.75611674 |
| 68 | forebrain neuron development (GO:0021884) | 2.74695193 |
| 69 | phospholipid translocation (GO:0045332) | 2.74655046 |
| 70 | lipid translocation (GO:0034204) | 2.74655046 |
| 71 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74376911 |
| 72 | positive regulation of steroid hormone secretion (GO:2000833) | 2.73754952 |
| 73 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.70590041 |
| 74 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.69704911 |
| 75 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.69689700 |
| 76 | oxidative demethylation (GO:0070989) | 2.68237881 |
| 77 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.68130023 |
| 78 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.68130023 |
| 79 | interferon-gamma production (GO:0032609) | 2.67424432 |
| 80 | protein localization to Golgi apparatus (GO:0034067) | 2.66734683 |
| 81 | positive regulation of digestive system process (GO:0060456) | 2.66687216 |
| 82 | kynurenine metabolic process (GO:0070189) | 2.66642607 |
| 83 | CENP-A containing nucleosome assembly (GO:0034080) | 2.66392174 |
| 84 | prostate gland growth (GO:0060736) | 2.64544491 |
| 85 | DNA topological change (GO:0006265) | 2.62924656 |
| 86 | nucleobase catabolic process (GO:0046113) | 2.62562679 |
| 87 | nucleus localization (GO:0051647) | 2.59109426 |
| 88 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.58459748 |
| 89 | chromatin remodeling at centromere (GO:0031055) | 2.57419864 |
| 90 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.55328546 |
| 91 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.54838462 |
| 92 | synapse assembly (GO:0007416) | 2.54647425 |
| 93 | neuron recognition (GO:0008038) | 2.54357416 |
| 94 | centrosome duplication (GO:0051298) | 2.54296066 |
| 95 | histone exchange (GO:0043486) | 2.53167077 |
| 96 | resolution of meiotic recombination intermediates (GO:0000712) | 2.53067263 |
| 97 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.53035767 |
| 98 | ncRNA catabolic process (GO:0034661) | 2.52684181 |
| 99 | male meiosis (GO:0007140) | 2.51887162 |
| 100 | response to X-ray (GO:0010165) | 2.51880198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.81904553 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.67895670 |
| 3 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.64151049 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.59062669 |
| 5 | FUS_26573619_Chip-Seq_HEK293_Human | 3.38736487 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.13940208 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.12387120 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.05369865 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.86807199 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.85344615 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.84966768 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.81551702 |
| 13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.39940944 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.36305480 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.36178450 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 2.34801493 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.33525051 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.13688416 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.12049408 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 2.09385686 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.01984746 |
| 22 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.97360571 |
| 23 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.92303949 |
| 24 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.90040996 |
| 25 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.89137075 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87510849 |
| 27 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87397634 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.87065374 |
| 29 | STAT3_23295773_ChIP-Seq_U87_Human | 1.85223667 |
| 30 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.72843606 |
| 31 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.72843606 |
| 32 | TCF4_23295773_ChIP-Seq_U87_Human | 1.68003537 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67173542 |
| 34 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.60477048 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58922666 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56729812 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55258865 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.53922315 |
| 39 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.47528577 |
| 40 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.40998084 |
| 41 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40326296 |
| 42 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.39999004 |
| 43 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39713543 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35351102 |
| 45 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34913833 |
| 46 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.34004479 |
| 47 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33309058 |
| 48 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.33117093 |
| 49 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.31857732 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31800370 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.31800370 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31090635 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30800759 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30343589 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30238240 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28657027 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24633361 |
| 58 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.23358655 |
| 59 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.23152454 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21912811 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21351008 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19901505 |
| 63 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.19686699 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17941310 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17713275 |
| 66 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16907815 |
| 67 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15269488 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14512498 |
| 69 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14096191 |
| 70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13714598 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13476618 |
| 72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13181509 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.11132236 |
| 74 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11051147 |
| 75 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10027451 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09031827 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08437112 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07029395 |
| 79 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05488142 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04081964 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03862153 |
| 82 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03392465 |
| 83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03019589 |
| 84 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02473065 |
| 85 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02458486 |
| 86 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02409472 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02360294 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00516558 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98178563 |
| 90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96603443 |
| 91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96527279 |
| 92 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96076468 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 0.95787468 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95409437 |
| 95 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95265513 |
| 96 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.93655753 |
| 97 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93257720 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93169809 |
| 99 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92823868 |
| 100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92330849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.15424304 |
| 2 | MP0010386_abnormal_urinary_bladder | 4.23570017 |
| 3 | MP0000516_abnormal_urinary_system | 4.00138143 |
| 4 | MP0005367_renal/urinary_system_phenotyp | 4.00138143 |
| 5 | MP0003880_abnormal_central_pattern | 3.94213023 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 3.16432539 |
| 7 | MP0008057_abnormal_DNA_replication | 3.07563435 |
| 8 | MP0002736_abnormal_nociception_after | 2.95439323 |
| 9 | MP0002102_abnormal_ear_morphology | 2.48462823 |
| 10 | MP0005670_abnormal_white_adipose | 2.27980140 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.24548213 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.19135086 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.17228692 |
| 14 | MP0005253_abnormal_eye_physiology | 2.11770122 |
| 15 | MP0001486_abnormal_startle_reflex | 1.92449320 |
| 16 | MP0003252_abnormal_bile_duct | 1.88696077 |
| 17 | MP0000372_irregular_coat_pigmentation | 1.85490635 |
| 18 | MP0006292_abnormal_olfactory_placode | 1.84885571 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.77482237 |
| 20 | MP0003221_abnormal_cardiomyocyte_apopto | 1.77113547 |
| 21 | MP0001529_abnormal_vocalization | 1.73543452 |
| 22 | MP0002095_abnormal_skin_pigmentation | 1.63427908 |
| 23 | MP0005187_abnormal_penis_morphology | 1.58762259 |
| 24 | MP0005174_abnormal_tail_pigmentation | 1.54927990 |
| 25 | MP0008058_abnormal_DNA_repair | 1.51489554 |
| 26 | MP0002751_abnormal_autonomic_nervous | 1.50920181 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.40642255 |
| 28 | MP0009745_abnormal_behavioral_response | 1.37908685 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.35806466 |
| 30 | MP0001177_atelectasis | 1.33816599 |
| 31 | MP0005248_abnormal_Harderian_gland | 1.32436029 |
| 32 | MP0009697_abnormal_copulation | 1.31600178 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.30016454 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.19968749 |
| 35 | MP0003195_calcinosis | 1.19713946 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.17239687 |
| 37 | MP0000371_diluted_coat_color | 1.17107744 |
| 38 | MP0004133_heterotaxia | 1.15598655 |
| 39 | MP0009046_muscle_twitch | 1.13145373 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.12882835 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.12305502 |
| 42 | MP0005266_abnormal_metabolism | 1.08648806 |
| 43 | MP0001324_abnormal_eye_pigmentation | 1.07471954 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.07171085 |
| 45 | MP0004043_abnormal_pH_regulation | 1.06610995 |
| 46 | MP0002272_abnormal_nervous_system | 1.05868896 |
| 47 | MP0001984_abnormal_olfaction | 1.02801860 |
| 48 | MP0003011_delayed_dark_adaptation | 1.02343312 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.02263128 |
| 50 | MP0003937_abnormal_limbs/digits/tail_de | 1.01839186 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.00984890 |
| 52 | MP0003879_abnormal_hair_cell | 0.98693016 |
| 53 | MP0010307_abnormal_tumor_latency | 0.98677531 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 0.97989473 |
| 55 | MP0002160_abnormal_reproductive_system | 0.97855010 |
| 56 | MP0000427_abnormal_hair_cycle | 0.97373060 |
| 57 | MP0004142_abnormal_muscle_tone | 0.95917259 |
| 58 | MP0002067_abnormal_sensory_capabilities | 0.93646637 |
| 59 | MP0005646_abnormal_pituitary_gland | 0.93436534 |
| 60 | MP0000631_abnormal_neuroendocrine_gland | 0.93056136 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.92949521 |
| 62 | MP0005391_vision/eye_phenotype | 0.92649399 |
| 63 | MP0003635_abnormal_synaptic_transmissio | 0.92145582 |
| 64 | MP0003693_abnormal_embryo_hatching | 0.91602828 |
| 65 | MP0003646_muscle_fatigue | 0.90675479 |
| 66 | MP0002229_neurodegeneration | 0.88431736 |
| 67 | MP0002184_abnormal_innervation | 0.87763113 |
| 68 | MP0001145_abnormal_male_reproductive | 0.86548591 |
| 69 | MP0002063_abnormal_learning/memory/cond | 0.85951262 |
| 70 | MP0001270_distended_abdomen | 0.85650471 |
| 71 | MP0000653_abnormal_sex_gland | 0.84475745 |
| 72 | MP0003698_abnormal_male_reproductive | 0.84317722 |
| 73 | MP0004924_abnormal_behavior | 0.83267035 |
| 74 | MP0005386_behavior/neurological_phenoty | 0.83267035 |
| 75 | MP0002882_abnormal_neuron_morphology | 0.82544453 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.80656118 |
| 77 | MP0002735_abnormal_chemical_nociception | 0.80288657 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.77318824 |
| 79 | MP0002210_abnormal_sex_determination | 0.76809975 |
| 80 | MP0003718_maternal_effect | 0.75728721 |
| 81 | MP0003119_abnormal_digestive_system | 0.74992804 |
| 82 | MP0005083_abnormal_biliary_tract | 0.72556045 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.72438402 |
| 84 | MP0005195_abnormal_posterior_eye | 0.71608753 |
| 85 | MP0000383_abnormal_hair_follicle | 0.71559844 |
| 86 | MP0002928_abnormal_bile_duct | 0.71264138 |
| 87 | MP0000778_abnormal_nervous_system | 0.71247193 |
| 88 | MP0002064_seizures | 0.70638738 |
| 89 | MP0009115_abnormal_fat_cell | 0.70416210 |
| 90 | MP0001929_abnormal_gametogenesis | 0.70336993 |
| 91 | MP0000955_abnormal_spinal_cord | 0.70197898 |
| 92 | MP0004811_abnormal_neuron_physiology | 0.68746689 |
| 93 | MP0003077_abnormal_cell_cycle | 0.68716436 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.68275282 |
| 95 | MP0005408_hypopigmentation | 0.67218025 |
| 96 | MP0002938_white_spotting | 0.66754965 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.66389303 |
| 98 | MP0000358_abnormal_cell_content/ | 0.65810277 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.65292662 |
| 100 | MP0001188_hyperpigmentation | 0.64224610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Failure to thrive in infancy (HP:0001531) | 4.80630657 |
| 2 | Febrile seizures (HP:0002373) | 4.73946079 |
| 3 | Genetic anticipation (HP:0003743) | 4.66041926 |
| 4 | Gaze-evoked nystagmus (HP:0000640) | 3.68710152 |
| 5 | Papillary thyroid carcinoma (HP:0002895) | 3.66181780 |
| 6 | Prostate neoplasm (HP:0100787) | 3.61277524 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.59239121 |
| 8 | Rib fusion (HP:0000902) | 3.32831440 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 3.16357720 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 3.16357720 |
| 11 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.11847546 |
| 12 | Focal motor seizures (HP:0011153) | 3.06864215 |
| 13 | Dysmetric saccades (HP:0000641) | 3.02713389 |
| 14 | Action tremor (HP:0002345) | 2.91838795 |
| 15 | Drooling (HP:0002307) | 2.81987960 |
| 16 | Intestinal atresia (HP:0011100) | 2.72096258 |
| 17 | Medial flaring of the eyebrow (HP:0010747) | 2.71792287 |
| 18 | Thyroid carcinoma (HP:0002890) | 2.70130566 |
| 19 | Pancreatic fibrosis (HP:0100732) | 2.69642894 |
| 20 | Absent speech (HP:0001344) | 2.68723806 |
| 21 | Pancreatic cysts (HP:0001737) | 2.66894001 |
| 22 | Postnatal microcephaly (HP:0005484) | 2.64221467 |
| 23 | Abnormal protein glycosylation (HP:0012346) | 2.64043929 |
| 24 | Abnormal glycosylation (HP:0012345) | 2.64043929 |
| 25 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.64043929 |
| 26 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.64043929 |
| 27 | Excessive salivation (HP:0003781) | 2.59031709 |
| 28 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.57926126 |
| 29 | Congenital primary aphakia (HP:0007707) | 2.52149700 |
| 30 | Oculomotor apraxia (HP:0000657) | 2.50198866 |
| 31 | Hyperventilation (HP:0002883) | 2.49120518 |
| 32 | Renal cortical cysts (HP:0000803) | 2.48337665 |
| 33 | Gait imbalance (HP:0002141) | 2.46111424 |
| 34 | Fair hair (HP:0002286) | 2.44492529 |
| 35 | Postaxial foot polydactyly (HP:0001830) | 2.38848073 |
| 36 | Abnormal biliary tract physiology (HP:0012439) | 2.35550549 |
| 37 | Bile duct proliferation (HP:0001408) | 2.35550549 |
| 38 | Pendular nystagmus (HP:0012043) | 2.34703824 |
| 39 | Narrow forehead (HP:0000341) | 2.34599634 |
| 40 | Cerebellar dysplasia (HP:0007033) | 2.34591331 |
| 41 | Widely spaced teeth (HP:0000687) | 2.33052603 |
| 42 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30513041 |
| 43 | True hermaphroditism (HP:0010459) | 2.30499400 |
| 44 | Renal hypoplasia (HP:0000089) | 2.30087803 |
| 45 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.29633361 |
| 46 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.29633361 |
| 47 | Dialeptic seizures (HP:0011146) | 2.29600103 |
| 48 | Focal seizures (HP:0007359) | 2.28608577 |
| 49 | Abnormality of the astrocytes (HP:0100707) | 2.26570307 |
| 50 | Astrocytoma (HP:0009592) | 2.26570307 |
| 51 | Pelvic girdle muscle weakness (HP:0003749) | 2.26120397 |
| 52 | Protruding tongue (HP:0010808) | 2.22636792 |
| 53 | Abnormality of the renal cortex (HP:0011035) | 2.22567855 |
| 54 | Hemiparesis (HP:0001269) | 2.20945531 |
| 55 | Impaired vibratory sensation (HP:0002495) | 2.20377112 |
| 56 | Poor coordination (HP:0002370) | 2.18192816 |
| 57 | Median cleft lip (HP:0000161) | 2.16564451 |
| 58 | Amyotrophic lateral sclerosis (HP:0007354) | 2.14507740 |
| 59 | Shoulder girdle muscle weakness (HP:0003547) | 2.14124622 |
| 60 | Lissencephaly (HP:0001339) | 2.10503677 |
| 61 | Nephronophthisis (HP:0000090) | 2.09308340 |
| 62 | Split foot (HP:0001839) | 2.08014645 |
| 63 | Abnormality of the renal medulla (HP:0100957) | 2.07501981 |
| 64 | Hypoplastic labia majora (HP:0000059) | 2.07199398 |
| 65 | Colon cancer (HP:0003003) | 2.04041419 |
| 66 | Epidermoid cyst (HP:0200040) | 2.01913493 |
| 67 | Glioma (HP:0009733) | 1.98782385 |
| 68 | Inability to walk (HP:0002540) | 1.96730386 |
| 69 | Absence seizures (HP:0002121) | 1.95489816 |
| 70 | Chronic hepatic failure (HP:0100626) | 1.94310340 |
| 71 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.94139377 |
| 72 | Short 4th metacarpal (HP:0010044) | 1.94139377 |
| 73 | Genital tract atresia (HP:0001827) | 1.93553256 |
| 74 | Short tibia (HP:0005736) | 1.92638664 |
| 75 | Severe global developmental delay (HP:0011344) | 1.92144944 |
| 76 | Postaxial hand polydactyly (HP:0001162) | 1.91913022 |
| 77 | Abnormality of the labia majora (HP:0012881) | 1.91535123 |
| 78 | Polymicrogyria (HP:0002126) | 1.91311372 |
| 79 | Vaginal atresia (HP:0000148) | 1.89921151 |
| 80 | Generalized hypopigmentation of hair (HP:0011358) | 1.89409783 |
| 81 | Progressive inability to walk (HP:0002505) | 1.88146062 |
| 82 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.87862550 |
| 83 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.87862550 |
| 84 | Cortical dysplasia (HP:0002539) | 1.86769026 |
| 85 | Spastic paraplegia (HP:0001258) | 1.86703008 |
| 86 | Proximal amyotrophy (HP:0007126) | 1.85854219 |
| 87 | Neoplasm of the heart (HP:0100544) | 1.83858528 |
| 88 | Retinal dysplasia (HP:0007973) | 1.83154269 |
| 89 | Abnormality of the prostate (HP:0008775) | 1.81300682 |
| 90 | Abnormality of the hepatic vasculature (HP:0006707) | 1.81156264 |
| 91 | Ependymoma (HP:0002888) | 1.77969400 |
| 92 | Abnormality of DNA repair (HP:0003254) | 1.76441861 |
| 93 | Hyperglycinemia (HP:0002154) | 1.76196983 |
| 94 | Abnormal auditory evoked potentials (HP:0006958) | 1.76022348 |
| 95 | Lower limb muscle weakness (HP:0007340) | 1.74442399 |
| 96 | Inappropriate behavior (HP:0000719) | 1.74281318 |
| 97 | Sloping forehead (HP:0000340) | 1.73390037 |
| 98 | Abnormality of chromosome stability (HP:0003220) | 1.72555814 |
| 99 | Birth length less than 3rd percentile (HP:0003561) | 1.72185307 |
| 100 | Paraplegia (HP:0010550) | 1.72005551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.78542979 |
| 2 | MAP3K4 | 4.56173525 |
| 3 | MAP2K7 | 3.84819147 |
| 4 | CDK19 | 3.34207555 |
| 5 | FGFR3 | 3.18980415 |
| 6 | MAPK13 | 2.27640805 |
| 7 | STK38L | 2.21553903 |
| 8 | BCR | 2.17914281 |
| 9 | TAF1 | 2.14551190 |
| 10 | NTRK3 | 2.10303948 |
| 11 | MAP3K6 | 2.09539599 |
| 12 | DYRK1A | 2.00999864 |
| 13 | TRIM28 | 1.98928101 |
| 14 | OXSR1 | 1.93718288 |
| 15 | ERBB3 | 1.88094773 |
| 16 | WNK3 | 1.85185679 |
| 17 | SRPK1 | 1.77527605 |
| 18 | MKNK2 | 1.76691818 |
| 19 | MAP2K4 | 1.76371851 |
| 20 | AKT3 | 1.55308394 |
| 21 | EPHA4 | 1.43483283 |
| 22 | MAP4K2 | 1.41105405 |
| 23 | ZAK | 1.40835148 |
| 24 | MKNK1 | 1.40441291 |
| 25 | PIK3CA | 1.39749524 |
| 26 | DYRK3 | 1.36752067 |
| 27 | STK38 | 1.35796354 |
| 28 | MAP3K5 | 1.23322471 |
| 29 | MARK1 | 1.21920941 |
| 30 | CASK | 1.10343493 |
| 31 | ACVR1B | 1.06897186 |
| 32 | NEK1 | 1.04015937 |
| 33 | PBK | 0.94701070 |
| 34 | BRSK2 | 0.92459080 |
| 35 | OBSCN | 0.90358591 |
| 36 | RPS6KA4 | 0.88101136 |
| 37 | TEC | 0.87984140 |
| 38 | SGK2 | 0.87944847 |
| 39 | NUAK1 | 0.87257725 |
| 40 | CAMKK2 | 0.85114638 |
| 41 | CSNK1A1L | 0.83428834 |
| 42 | CDK3 | 0.83094770 |
| 43 | CSNK1G2 | 0.82963209 |
| 44 | PLK4 | 0.81672419 |
| 45 | BLK | 0.81479051 |
| 46 | EPHA3 | 0.81414474 |
| 47 | DYRK1B | 0.79831098 |
| 48 | ERBB2 | 0.78019358 |
| 49 | VRK1 | 0.77953086 |
| 50 | ATR | 0.76186548 |
| 51 | BMPR2 | 0.76039503 |
| 52 | ADRBK2 | 0.73377935 |
| 53 | MAP3K7 | 0.71788712 |
| 54 | CSNK1G3 | 0.63010661 |
| 55 | ATM | 0.62665659 |
| 56 | CSNK1G1 | 0.61794304 |
| 57 | ERBB4 | 0.61025149 |
| 58 | BMPR1B | 0.60560585 |
| 59 | SGK1 | 0.58372203 |
| 60 | TRPM7 | 0.55931659 |
| 61 | PLK3 | 0.54837055 |
| 62 | PLK1 | 0.54098159 |
| 63 | PLK2 | 0.53493486 |
| 64 | GRK1 | 0.53384986 |
| 65 | SGK223 | 0.52700839 |
| 66 | SGK494 | 0.52700839 |
| 67 | DYRK2 | 0.52405615 |
| 68 | TTK | 0.52196073 |
| 69 | FLT3 | 0.51177806 |
| 70 | CAMK4 | 0.46811164 |
| 71 | TAOK3 | 0.46627748 |
| 72 | RPS6KA5 | 0.45851821 |
| 73 | PIM1 | 0.45407343 |
| 74 | LATS1 | 0.44090951 |
| 75 | STK11 | 0.43901599 |
| 76 | SIK2 | 0.43628292 |
| 77 | CAMK2A | 0.42034429 |
| 78 | RPS6KB1 | 0.41267774 |
| 79 | TLK1 | 0.40734771 |
| 80 | CLK1 | 0.40396514 |
| 81 | FER | 0.39933284 |
| 82 | PKN1 | 0.39073475 |
| 83 | INSRR | 0.38914743 |
| 84 | STK4 | 0.38320946 |
| 85 | AURKB | 0.36723037 |
| 86 | TXK | 0.36577731 |
| 87 | CAMK2B | 0.35734619 |
| 88 | PIM2 | 0.35386731 |
| 89 | WNK1 | 0.35120447 |
| 90 | PRKACB | 0.34862894 |
| 91 | NEK6 | 0.33225165 |
| 92 | CHEK1 | 0.31172700 |
| 93 | RET | 0.30602790 |
| 94 | PRKG1 | 0.30224070 |
| 95 | CSNK1E | 0.29825402 |
| 96 | PRKCE | 0.28924926 |
| 97 | EGFR | 0.27912159 |
| 98 | CSNK1D | 0.27079325 |
| 99 | PINK1 | 0.26745105 |
| 100 | CHEK2 | 0.24769015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.95520726 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.80944802 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.26698482 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18542419 |
| 5 | * Taste transduction_Homo sapiens_hsa04742 | 2.92051765 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.55241527 |
| 7 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.30376369 |
| 8 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.22851977 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20824308 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02515917 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.95035703 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.92004517 |
| 13 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.86179784 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79622311 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.77181764 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.70444768 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69718945 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60439687 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.52092776 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46471707 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.46378822 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.45862149 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.41651367 |
| 24 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.35681561 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.33897407 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.30518460 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.23708309 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21278868 |
| 29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.15883729 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.07323489 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06839925 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06717352 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03969512 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02990185 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.01463146 |
| 36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01194067 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01005280 |
| 38 | Alcoholism_Homo sapiens_hsa05034 | 0.99088630 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97773389 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92857005 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91880532 |
| 42 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91036271 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90838473 |
| 44 | Morphine addiction_Homo sapiens_hsa05032 | 0.90086803 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 0.89792574 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86373775 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85987841 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85619972 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85058740 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82286731 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81087494 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78084711 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.77796446 |
| 54 | Cell cycle_Homo sapiens_hsa04110 | 0.75985501 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.75302361 |
| 56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72778746 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72108045 |
| 58 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67672383 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67552529 |
| 60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66834490 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64802218 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 0.62867556 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61167542 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60937951 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57950882 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57259019 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57136811 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56428579 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56179484 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55183644 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.54942043 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52455843 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52319332 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.52260038 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.49469674 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.47308496 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46054410 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45371465 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.43266487 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42901418 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.42377404 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42111221 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41827929 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.41587178 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41036170 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40611128 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35994843 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35666317 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35062817 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34725880 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34647048 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33921723 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32135942 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31563893 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31447585 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.30691979 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29597508 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29370552 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28600436 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28282048 |

